Replies to post #90870 on Ayala Pharmaceuticals Inc (ADXS)

[SKTrader1]

If by Feb.21st this stock is still trading below .60 you have to know an R/S is coming. He is telegraphing this. Additionally, I just don’t see it getting voted down. The argument that hey we need more dilution or go out of business is usually too much to overcome. Not to mention not much oversight on the process either. So rarely see something like this voted down. To get any value from future dilution u need an R/S first as well as obvious need to stay listed according to ADXS. It’s being telegraphed.

Just know your amount of risk goes up quite a lot come Feb 21st and if you are hoping on everything being voted down as your life raft then you must have accepted a potential 100% loss. Which to some they rather gamble against the odds of losses becomes steep enough. That’s understandable but just know that is not how this market will react. So going into the 2/21 date there will be ppl jumping ship with a lot of sell pressure.

I do believe there is one more spike left with volume. I would personally cash out then and you can always come back in 30 days. 30k better than 0. Of course this is an individual choice but don’t say this hasn’t been clearly telegraphed for awhile.

KB are nothing but conjecture and hopeful idiot. You pull ur P3 from EMA then say may not be commercially viable to continue on own and HOT and NEO have better opportunities. Then also say looking for a partnership...look at their actions and the information we do have....if you look you will see nothing indicates any confidence by the company to land a $ deal.

There will be one more spike but I could easily see this touching .15 going into Feb.21st unless there some manipulation to keep price at reasonable level for the split.

Tick-Tock useless KB. We are not dumb and we can see the writing on the wall. Either put up or take what cash is left and sell off science in a open bid and return that money to the shareholders whatever you get. Then fire every single useless employee that collected paychecks off backs of shareholders and nothing more.